Bath & Body Works (NYSE:BBWI) Stock Price Expected to Rise, TD Cowen Analyst Says

Bath & Body Works (NYSE:BBWI) had its price target increased by analysts at TD Cowen from $40.00 to $42.00 in a report issued on Tuesday,Benzinga reports. The brokerage presently has a “buy” rating on the stock. TD Cowen’s target price indicates a potential upside of 16.93% from the stock’s current price.

BBWI has been the topic of a number of other reports. Citigroup cut their target price on shares of Bath & Body Works from $48.00 to $35.00 and set a “neutral” rating on the stock in a report on Tuesday, August 20th. BMO Capital Markets restated an “outperform” rating and issued a $50.00 price objective (down from $52.00) on shares of Bath & Body Works in a research note on Thursday, August 29th. Morgan Stanley lowered their price target on Bath & Body Works from $51.00 to $48.00 and set an “overweight” rating on the stock in a report on Thursday, November 21st. UBS Group reduced their price objective on Bath & Body Works from $52.00 to $38.00 and set a “neutral” rating for the company in a research note on Thursday, August 29th. Finally, Raymond James lowered their target price on Bath & Body Works from $51.00 to $42.00 and set an “outperform” rating on the stock in a research note on Thursday, August 29th. One investment analyst has rated the stock with a sell rating, six have issued a hold rating and nine have assigned a buy rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $41.88.

Bath & Body Works Stock Performance

Shares of BBWI stock opened at $35.92 on Tuesday. Bath & Body Works has a 1 year low of $26.20 and a 1 year high of $52.99. The firm has a market cap of $7.87 billion, a price-to-earnings ratio of 8.83, a PEG ratio of 1.14 and a beta of 1.79. The stock’s 50-day moving average is $30.81 and its two-hundred day moving average is $35.65.

Bath & Body Works (NYSE:BBWI) last released its quarterly earnings results on Wednesday, August 28th. The company reported $0.37 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.35 by $0.02. Bath & Body Works had a negative return on equity of 44.03% and a net margin of 12.43%. The firm had revenue of $1.53 billion for the quarter, compared to the consensus estimate of $1.54 billion. As a group, research analysts predict that Bath & Body Works will post 3.18 EPS for the current year.

Insider Buying and Selling at Bath & Body Works

In other Bath & Body Works news, CEO Gina Boswell acquired 6,000 shares of the company’s stock in a transaction dated Wednesday, October 9th. The stock was acquired at an average cost of $29.64 per share, with a total value of $177,840.00. Following the purchase, the chief executive officer now directly owns 242,987 shares in the company, valued at approximately $7,202,134.68. This trade represents a 2.53 % increase in their position. The acquisition was disclosed in a filing with the SEC, which is available through this link. 0.27% of the stock is currently owned by insiders.

Institutional Investors Weigh In On Bath & Body Works

A number of large investors have recently bought and sold shares of the stock. First Community Trust NA acquired a new position in shares of Bath & Body Works in the second quarter worth $30,000. True Wealth Design LLC raised its stake in Bath & Body Works by 5,270.0% in the 3rd quarter. True Wealth Design LLC now owns 1,074 shares of the company’s stock valued at $34,000 after purchasing an additional 1,054 shares during the last quarter. Livforsakringsbolaget Skandia Omsesidigt lifted its holdings in Bath & Body Works by 300.0% in the 3rd quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 1,200 shares of the company’s stock valued at $38,000 after purchasing an additional 900 shares in the last quarter. Wilmington Savings Fund Society FSB purchased a new position in Bath & Body Works in the 3rd quarter valued at about $39,000. Finally, TD Private Client Wealth LLC boosted its stake in shares of Bath & Body Works by 24.2% during the 3rd quarter. TD Private Client Wealth LLC now owns 1,697 shares of the company’s stock worth $54,000 after purchasing an additional 331 shares during the last quarter. Institutional investors and hedge funds own 95.14% of the company’s stock.

Bath & Body Works Company Profile

Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.